This most current twist while in the Lykos Therapeutics saga threatens A serious overhaul of the corporation’s system and course, with Musk ally and billionaire investor Antonio Gracias appearing to wish to take the company again toward its nonprofit drug enhancement roots and a more Doblinite philosophy.By signing up for the copyright Highlight